company background image
000999 logo

China Resources Sanjiu Medical & Pharmaceutical XSEC:000999 Stock Report

Last Price

CN¥46.40

Market Cap

CN¥59.6b

7D

2.6%

1Y

22.6%

Updated

22 Dec, 2024

Data

Company Financials +

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

XSEC:000999 Stock Report

Market Cap: CN¥59.6b

My Notes

Capture your thoughts, links and company narrative

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for China Resources Sanjiu Medical & Pharmaceutical
Historical stock prices
Current Share PriceCN¥46.40
52 Week HighCN¥52.55
52 Week LowCN¥36.24
Beta0.40
1 Month Change1.55%
3 Month Change22.11%
1 Year Change22.60%
3 Year Change102.89%
5 Year Change101.87%
Change since IPO126.00%

Recent News & Updates

Recent updates

Shareholder Returns

000999CN PharmaceuticalsCN Market
7D2.6%-1.9%-1.2%
1Y22.6%-1.8%11.8%

Return vs Industry: 000999 exceeded the CN Pharmaceuticals industry which returned -1.8% over the past year.

Return vs Market: 000999 exceeded the CN Market which returned 11.8% over the past year.

Price Volatility

Is 000999's price volatile compared to industry and market?
000999 volatility
000999 Average Weekly Movement6.0%
Pharmaceuticals Industry Average Movement7.4%
Market Average Movement8.7%
10% most volatile stocks in CN Market12.8%
10% least volatile stocks in CN Market5.7%

Stable Share Price: 000999 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 000999's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199920,318n/awww.999.com.cn

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People’s Republic of China and internationally. The company offers health consumer products (CHC), including cold, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products, such as anti-tumor, cardiovascular and cerebrovascular, digestive system, orthopedics, pediatrics, and other treatment areas; Chinese medicine injections; formula granules; and anti-infective drugs.

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Fundamentals Summary

How do China Resources Sanjiu Medical & Pharmaceutical's earnings and revenue compare to its market cap?
000999 fundamental statistics
Market capCN¥59.59b
Earnings (TTM)CN¥3.41b
Revenue (TTM)CN¥25.87b

17.5x

P/E Ratio

2.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
000999 income statement (TTM)
RevenueCN¥25.87b
Cost of RevenueCN¥12.10b
Gross ProfitCN¥13.78b
Other ExpensesCN¥10.36b
EarningsCN¥3.41b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)2.66
Gross Margin53.24%
Net Profit Margin13.18%
Debt/Equity Ratio10.0%

How did 000999 perform over the long term?

See historical performance and comparison

Dividends

4.3%

Current Dividend Yield

81%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 15:32
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is covered by 42 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Changming HeBOCI Research Ltd.
Jessica LiBofA Global Research
Shuchang LiuChangjiang Securities Co. LTD.